MYSM-1 suppresses migration and invasion in renal carcinoma through inhibiting epithelial-mesenchymal transition

Lei Zhou1, Liyin Shi2, Hua Guo1

  • 1National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China.

Insights

MYSM-1 is downregulated in renal cell carcinoma (RCC) and suppresses its metastasis. Low MYSM-1 expression correlates with poor prognosis, indicating its potential as a therapeutic target for kidney cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Renal cell carcinoma (RCC) is the most common kidney cancer, characterized by high metastatic potential.
  • The molecular mechanisms driving RCC metastasis are not fully understood.
  • Previous proteomics studies indicated MYSM-1 downregulation in non-metastatic RCC tissues.

Purpose of the Study:

  • To investigate the expression status of MYSM-1 in renal cell carcinoma (RCC).
  • To determine the correlation between MYSM-1 expression and RCC patient prognosis and metastasis.
  • To elucidate the biological role of MYSM-1 in RCC cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT).

Main Methods:

  • Immunohistochemistry on renal carcinoma tissue microarrays to assess MYSM-1 expression.
  • In vitro studies using renal carcinoma cell lines with MYSM-1 knockdown (siRNA) and overexpression.
  • Assessment of cell proliferation, migration, invasion, and EMT markers.

Main Results:

  • MYSM-1 expression was significantly decreased in renal carcinoma tissues compared to normal controls.
  • Low MYSM-1 expression was strongly associated with poor overall prognosis and increased metastasis.
  • MYSM-1 suppressed renal cell carcinoma cell proliferation, migration, and invasion.
  • MYSM-1 was found to inhibit the epithelial-mesenchymal transition (EMT) process.

Conclusions:

  • MYSM-1 acts as a tumor suppressor in renal cell carcinoma.
  • Downregulation of MYSM-1 is linked to aggressive disease and metastasis in RCC.
  • MYSM-1 may inhibit RCC metastasis by suppressing EMT, suggesting its potential as a therapeutic target.

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Role of Myosin in Cell Migration01:18

Role of Myosin in Cell Migration

Myosins are multimeric motor proteins involved in various cellular processes such as migration, adhesion, and proliferation. Myosin II is the most common type in animal cells, which binds and cross-links actin filaments.
Myosin II  is a hexamer comprising two heavy chains with globular heads and coiled-coil tails, two regulatory light chains, and two essential light chains. The ATPase sites on the myosin heads hydrolyze ATP, and the released phosphate generates the force for contraction....
3.7K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Cell Migration01:19

Cell Migration

Cell migration is a process by which the cells move from one location to another, playing an essential role in embryological development, repair and regeneration, immune response, and metastasis. Cells migrate in response to chemical or mechanical signals generated by specific organs or tissues. The overall mechanism includes three steps - polarization, protrusion, and release. Polarization involves the formation of a distinct cell front and rear, which determines the direction of movement.
7.4K
Cytoskeletal Coordination in Cell Migration01:32

Cytoskeletal Coordination in Cell Migration

A migrating cell changes its shape during the cyclic events of attachment and detachment from the substratum and repositions the cell organelles correspondingly. These complex events are orchestrated by the dynamic cytoskeletal network comprising actin filaments, intermediate filaments, and microtubules. Cytoskeletal crosstalk — the direct and indirect communication between the different components — is crucial for this coordination. Direct communication involves various linker...
5.7K